A
$ Value
$0
Shares
175,299
Price
$0
Filed
Jul 28
Insider
Name
Neal James R
Title
—
CIK
0001600865
Roles
Director
Transaction Details
Transaction Date
2025-07-24
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
206,505
Footnotes
Restricted stock granted under the Processa Pharmaceuticals, Inc. 2019 Omnibus Incentive Plan ("Omnibus Plan"), of which 125,999 shares are subject to stockholder approval of the revised Omnibus Plan. | The restricted stock vest on the earlier of June 30, 2026 or the next annual meeting of stockholders, subject to certain distribution requirements.
Filing Info
Neal James R's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-31 | PCSA | ▲ | $2K ★ |
| 2025-12-16 | AKTX | ▲ | — |
| 2025-12-16 | AKTX | ▲ | $999 |
| 2025-12-16 | AKTX | ▲ | — |
| 2025-12-16 | AKTX | ▲ | $1K |
| 2025-10-01 | PCSA | A | $0 |
| 2025-10-01 | PCSA | A | $0 |
| 2025-07-24 | PCSA | A | $0 |
| 2024-09-03 | PCSA | A | $0 |
Other Insiders at PCSA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
SKIBSTED RUSSELL
Chief Financial Officer
|
$12K | — | 2026-04-15 |
|
Ng George K
Chief Executive Officer
|
$11K | — | 2026-04-15 |
|
Bigora Sian
Chief Development Officer
|
$11K | — | 2026-04-15 |
|
Guy Wendy
Chief Administrative Officer
|
$9K | — | 2026-04-15 |
|
Young David
Pres. Research & Development
|
$9K | — | 2026-04-15 |
|
Lin Patrick
Chief Business - Strategy Off
|
$8K | — | 2026-04-15 |
| Baluch Khoso | $6K | — | 2026-03-31 |
| Pannu Geraldine | $5K | — | 2026-03-31 |
| Neal James R | $2K | — | 2026-03-31 |